Wacker Chemie AG

Informe acción XTRA:WCH

Capitalización de mercado: €4.4b

Wacker Chemie Crecimiento futuro

Future controles de criterios 3/6

Se prevé un crecimiento anual de los beneficios y los ingresos de Wacker Chemie de 87.8% y 2.8% por año respectivamente. Se prevé que el BPA crezca en un 72.5% al año. Se espera que la rentabilidad financiera sea de 4.3% en 3 años.

Información clave

87.8%

Tasa de crecimiento de los beneficios

72.55%

Tasa de crecimiento del BPA

Crecimiento de los beneficios de Chemicals11.7%
Tasa de crecimiento de los ingresos2.8%
Rentabilidad financiera futura4.33%
Cobertura de analistas

Good

Última actualización07 Sep 2026

Actualizaciones recientes sobre el crecimiento futuro

Recent updates

Actualización de narrativa • Sep 03

WCH: Semi Cycle Caution And Margin Outlook Will Shape Fair Value

Analysts have trimmed their fair value estimate for Wacker Chemie to €104 from €110, reflecting a lower Street price target, now at €85, that is linked to concerns that recent share gains may already factor in much of the expected benefit from the semiconductor cycle. Analyst Commentary Recent Street research on Wacker Chemie has leaned cautious, with price targets centred around €85 and commentary that recent share gains may already reflect a large part of the expected benefit from the semiconductor cycle.
Actualización de narrativa • Aug 17

WCH: Semi Cycle Euphoria And 40% Rally Will Likely Cap Returns

Analysts have nudged their fair value estimate for Wacker Chemie higher to about €70 from about €67, citing higher Street price targets around €95 to €104 and arguing that recent share gains may already reflect much of the expected benefit from the semiconductor cycle. Analyst Commentary Recent Street commentary on Wacker Chemie highlights a more cautious tone after the stock's strong move, with several bearish analysts questioning how much upside is left at current levels.
Actualización de narrativa • Aug 03

WCH: Higher Margin Outlook Will Support Fair Value Beyond Post Rally Downgrades

Analysts now see a fair value for Wacker Chemie at €110 per share, with updated assumptions that include a slightly lower discount rate, a modest adjustment to revenue growth, a higher profit margin outlook, and a marginally lower future P/E. These revisions are informed by recent price target changes and more cautious views on how much the company may benefit from the semiconductor cycle after its strong share price rally.
Actualización de narrativa • Jul 20

WCH: Semi Cycle Optimism And Rally Will Likely Cap Future Returns

Analysts have raised the fair value estimate for Wacker Chemie from about €61.46 to roughly €66.76. This reflects updated views on margins and revenue potential, even as recent Street research has shifted to more cautious ratings following the stock's strong rally.
Actualización de narrativa • Jul 01

WCH: Elevated P/E And Semi Cycle Optimism Will Likely Undermine Future Returns

Wacker Chemie’s updated fair value estimate has moved from about €50 to roughly €61, as analysts lift price targets after the stock’s rally while highlighting more cautious assumptions on margins and the semi cycle. Analyst Commentary Recent research on Wacker Chemie points to a more balanced, and in parts cautious, stance after the share price rally, with several bearish analysts flagging valuation, execution, and growth risks even as some major banks lift price targets.
Actualización de narrativa • Jun 17

WCH: Future Returns Will Rely On Delivering Cautious 2026 Semiconductor Cycle Assumptions

The analyst price target for Wacker Chemie has moved higher from about €81 to about €89. Analysts point to revised assumptions on revenue growth, profit margins and future P/E multiples, even as some recent downgrades highlight concerns that the stock's rally may already reflect much of the expected benefit from the semiconductor cycle.
Actualización de narrativa • Jun 02

WCH: Higher P/E Assumptions Will Balance Rally With Measured Medium Term Upside

Analysts have raised their fair value estimate for Wacker Chemie from €96 to €110, citing a series of recent price target increases across the Street and updated assumptions for revenue growth, profit margins, and future P/E. Some now see more limited upside following the stock's strong run.
Actualización de narrativa • May 02

WCH: Future Returns Will Depend On Delivering Cautious 2026 Earnings Guidance

Analysts have lifted their fair value estimate for Wacker Chemie from €73.50 to about €81.43, citing updated assumptions on revenue growth, profitability and future P/E multiples following several recent upgrades and price target increases from major research houses. Analyst Commentary Bullish Takeaways Bullish analysts point to a series of recent upgrades as support for a higher fair value range, linking their stance to refreshed assumptions on revenue, margins and the P/E multiple they are willing to apply.
Actualización de narrativa • Apr 17

WCH: Supportive Research Tone Will Sustain Richer Future P/E Expectations

Analysts have nudged the fair value estimate for Wacker Chemie up to €96.00 from about €95.45, citing a higher assumed revenue growth rate, a revised future P/E of roughly 20.7, and a series of recent price target increases and upgrades from major banks. Analyst Commentary Recent Street research has tilted more supportive, with several bullish analysts revising their views in a way that reinforces the higher fair value estimate and the assumed future P/E of about 20.7. Some have raised price targets, including one increase to €61 from €59 alongside an Underweight rating, while others have moved to more positive stances through upgrades and more constructive commentary.
Actualización de narrativa • Apr 02

WCH: Future Returns Will Depend On Delivering Modest 2026 Guidance

Analysts have lifted the implied fair value estimate for Wacker Chemie from about €69.57 to €73.50. This reflects recent upgrades and a higher Street price target of €61, which collectively point to adjusted assumptions on revenue growth, margins and future P/E multiples.
Actualización de narrativa • Mar 18

WCH: Higher P/E Assumptions Will Likely Fail To Support Rich Share Price

Analysts have lifted their price target on Wacker Chemie to €61 from €59, reflecting updated views on revenue growth, profit margins and future P/E assumptions, while keeping the fair value estimate unchanged. Analyst Commentary Recent research on Wacker Chemie points to a mixed backdrop, with some price target adjustments reflecting caution around execution risks, earnings visibility and how the shares are valued against these factors.
Actualización de narrativa • Mar 04

WCH: Margin Execution Risks Will Likely Cap Share Upside Despite Upgrades

Analysts have raised their price target on Wacker Chemie to €50, citing firmer margin expectations and a lower assumed future P/E, supported by recent upgrades from major houses. Analyst Commentary Recent research reports on Wacker Chemie point to a more constructive view on margins and valuation, but you still see a strand of caution in the background.
Actualización de narrativa • Feb 18

WCH: Improved Earnings Profile Will Support Richer Future P/E Multiple

Analysts have trimmed their price target on Wacker Chemie to about €95 from roughly €108, citing revised expectations for revenue growth, profitability and a higher assumed future P/E multiple as key drivers of the change. Analyst Commentary Recent research has leaned more positive on Wacker Chemie, with bullish analysts pointing to a more constructive view on the company’s earnings power and how that could be reflected in the share price over time.
Actualización de narrativa • Feb 03

WCH: Fair Outlook Will Depend On Restructuring Progress And Section 232 Resolution

Analysts have nudged their fair value estimate for Wacker Chemie higher to €69.57 from €67.36, reflecting updated views on margins and P/E assumptions, alongside mixed rating actions from recent Street research. Analyst Commentary Recent Street research shows a split view on Wacker Chemie, with some analysts turning more positive while others take a more cautious stance around execution and policy risks.
Actualización de narrativa • Jan 20

WCH: Section 232 Uncertainty Will Likely Cap Near Term Share Upside

Analysts have adjusted their average price target for Wacker Chemie to €73, reflecting a more cautious stance that aligns with recent Neutral and Equal Weight views as they wait for clarity on Section 232 outcomes and the company’s restructuring plans. Analyst Commentary Recent commentary around Wacker Chemie has taken a more cautious tone, with coverage starting at a neutral stance and an existing recommendation cut back to Neutral alongside a €73 price target.
Actualización de narrativa • Jan 06

WCH: Fair Outlook Hinges On Restructuring Execution And Section 232 Outcome

Analysts have kept their fair value estimate for Wacker Chemie broadly unchanged at €67.36, with only modest tweaks to discount rate, growth and margin assumptions. They have also tempered their stance in light of mixed recent coverage and a Neutral rating with a €73 price target.
Artículo de análisis • Jan 05

Revenues Tell The Story For Wacker Chemie AG (ETR:WCH)

With a median price-to-sales (or "P/S") ratio of close to 0.6x in the Chemicals industry in Germany, you could be...
Actualización de narrativa • Dec 18

WCH: Restructuring Uncertainty And Trade Policy Risks Will Likely Pressure Shares

Analysts have modestly reduced their price targets for Wacker Chemie, trimming expectations by a few euros per share as they factor in slower revenue growth, thinner profit margins, and valuation headwinds while awaiting clarity on U.S. trade policy and the company restructuring. Analyst Commentary Bearish analysts have shifted to a more cautious stance on Wacker Chemie, emphasizing execution risks around the ongoing restructuring, uncertainty over U.S. trade policy decisions, and a less supportive earnings backdrop.
Actualización de narrativa • Dec 04

WCH: Future Performance Will Depend On Restructuring Progress And Section 232 Decisions

Analysts have trimmed their fair value estimate for Wacker Chemie by roughly EUR 1 to about EUR 67. This reflects slightly softer growth expectations and more cautious price targets following a wave of Neutral and Hold ratings.
Actualización de narrativa • Nov 20

WCH: Near-Term Performance Will Depend On Restructuring Progress And Policy Outcomes

Wacker Chemie's analyst price target has seen a modest decrease to €68.29 from €69, as analysts cite cautious outlooks regarding restructuring progress and ongoing external uncertainties. Analyst Commentary Recent analyst activity on Wacker Chemie has provided a spectrum of perspectives on the company’s outlook, as reflected in their updated ratings and price targets.
Actualización de narrativa • Nov 05

WCH: Future Earnings Will Face Margin Pressure As Cautious Outlook Persists

Wacker Chemie’s fair value estimate has been raised from €66.33 to €69.00. This change reflects analysts’ updated outlook based on adjusted forecasts for discount rates, future revenue growth, and profit margins.
Artículo de análisis • Oct 26

What Is Wacker Chemie AG's (ETR:WCH) Share Price Doing?

Wacker Chemie AG ( ETR:WCH ), might not be a large cap stock, but it saw a decent share price growth of 13% on the XTRA...
Actualización de narrativa • Oct 22

Analysts Mixed on Wacker Chemie as Price Targets Fall Amid Slightly Lower Growth Forecasts

Wacker Chemie's analyst price target has been revised downward from €68.92 to €66.33, with analysts citing slightly reduced expectations for revenue growth and profit margins as reasons for the change. Analyst Commentary Recent price target revisions for Wacker Chemie signal mixed sentiment in the market, as analysts evaluate the company’s prospects in light of changing expectations for revenue and profitability.
Actualización de narrativa • Oct 08

Polysilicon And Renewable Energy Investments Will Drive Future Value

Wacker Chemie's analyst price target has been revised downward, decreasing by approximately EUR 2.72 to EUR 68.92. Analysts note expectations for softer revenue growth and profit margins in their latest forecasts.
Artículo de análisis • Sep 29

Does Wacker Chemie (ETR:WCH) Have A Healthy Balance Sheet?

Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
Actualización de narrativa • Sep 19

Polysilicon And Renewable Energy Investments Will Drive Future Value

Analysts have lowered Wacker Chemie’s price target to €71.64, citing ongoing margin pressures, weak end-market demand, and reduced earnings visibility, driving a more cautious sector outlook. Analyst Commentary Bearish analysts cite continued margin pressures in key business segments, weighing on profit forecasts.
Actualización de narrativa • Sep 04

Polysilicon And Renewable Energy Investments Will Drive Future Value

Analysts have become more cautious on Wacker Chemie due to rising short-term earnings risks and macroeconomic uncertainty, resulting in price target downgrades and more conservative recommendations, with the consensus analyst price target unchanged at €75.79. Analyst Commentary Bearish analysts cite increased short-term risks to Wacker Chemie’s earnings momentum as a key factor behind lowered price targets.
User avatar
Nueva narrativa • Dec 22

Specialty Silicones And Biosolutions Expansion Will Propel Earnings And Boost Net Margins

Investment in specialty silicones and focus on high-margin specialties forecast improved net margins and earnings through enhanced portfolio management.

Previsiones de crecimiento de beneficios e ingresos

XTRA:WCH - Estimaciones futuras de los analistas y datos financieros pasados (EUR Millions)
FechaIngresosBeneficiosFlujo de caja libreFlujo de caja operativoNúm. de analistas medio
12/31/20286,1202162546499
12/31/20275,87216922558411
12/31/20265,7148119554311
6/30/20265,517-438316732N/A
3/31/20265,413-80335588N/A
12/31/20255,485-821-11543N/A
9/30/20255,56622-248404N/A
6/30/20255,656136-338352N/A
3/31/20255,711189-366286N/A
12/31/20245,722241-358337N/A
9/30/20245,770124-278362N/A
6/30/20245,863124-111572N/A
3/31/20246,148214163802N/A
12/31/20236,402314297936N/A
9/30/20236,846515279840N/A
6/30/20237,4567391901,021N/A
3/31/20237,8771,0024611,023N/A
12/31/20228,2091,2515641,126N/A
9/30/20228,0711,292665986N/A
6/30/20227,5971,2997081,030N/A
3/31/20226,9241,0878201,141N/A
12/31/20216,2088077431,064N/A
9/30/20215,758582N/AN/AN/A
6/30/20215,2834038721,098N/A
3/31/20214,854227N/AN/AN/A
12/31/20204,692189647874N/A
9/30/20204,609-619N/AN/AN/A
6/30/20204,693-599330745N/A
3/31/20204,889-568N/AN/AN/A
12/31/20194,928-643N/A605N/A
9/30/20194,961135N/A574N/A
6/30/20194,936117N/A403N/A
3/31/20194,997163N/A302N/A
12/31/20184,979246N/A510N/A
9/30/20184,966271N/A444N/A
6/30/20185,035308N/A600N/A
3/31/20184,923287N/A725N/A
12/31/20174,924232N/A657N/A
9/30/20174,900201N/A680N/A
6/30/20174,739160N/A718N/A
3/31/20174,720157N/A741N/A
12/31/20164,634168N/A737N/A
9/30/20164,716153N/A731N/A
6/30/20164,923154N/A623N/A
3/31/20165,094208N/A590N/A
12/31/20155,296247N/A617N/A
9/30/20155,258225N/A525N/A

Previsiones de crecimiento futuro de los analistas

Ingresos vs. Tasa de ahorro: Se prevé que WCH sea rentable en los próximos 3 años, lo que se considera un crecimiento más rápido que la tasa de ahorro (2.1%).

Beneficios vs. Mercado: Se prevé que WCH sea rentable en los próximos 3 años, lo que se considera un crecimiento del mercado superior a la media.

Beneficios de alto crecimiento: Se espera que WCH sea rentable en los próximos 3 años.

Ingresos vs. Mercado: Se prevé que los ingresos (2.8% al año) de WCH crezcan más despacio que el mercado de German (6.6% al año).

Ingresos de alto crecimiento: Se prevé que los ingresos 2.8% al año) de WCH crezcan más despacio que 20% al año.

Previsiones de crecimiento de los beneficios por acción

Rentabilidad financiera futura

ROE futura: Se prevé que la rentabilidad financiera de WCH sea baja dentro de 3 años (4.3%).

Descubre empresas en crecimiento

7D

1Y

7D

1Y

7D

1Y

Análisis de la empresa y estado de los datos financieros

DatosÚltima actualización (huso horario UTC)
Análisis de la empresa2026/09/11 23:22
Precio de las acciones al final del día2026/09/11 00:00
Beneficios2026/06/30
Ingresos anuales2025/12/31

Fuentes de datos

Los datos utilizados en nuestro análisis de empresas proceden de S&P Global Market Intelligence LLC. Los siguientes datos se utilizan en nuestro modelo de análisis para generar este informe. Los datos están normalizados, lo que puede introducir un retraso desde que la fuente está disponible.

PaqueteDatosMarco temporalEjemplo Fuente EE.UU. *
Finanzas de la empresa10 años
  • Cuenta de resultados
  • Estado de tesorería
  • Balance
Estimaciones del consenso de analistas+3 años
  • Previsiones financieras
  • Objetivos de precios de los analistas
Precios de mercado30 años
  • Precios de las acciones
  • Dividendos, escisiones y acciones
Propiedad10 años
  • Accionistas principales
  • Información privilegiada
Gestión10 años
  • Equipo directivo
  • Consejo de Administración
Principales avances10 años
  • Anuncios de empresas

* Ejemplo para valores de EE.UU., para no EE.UU. se utilizan formularios y fuentes normativas equivalentes.

A menos que se especifique lo contrario, todos los datos financieros se basan en un periodo anual, pero se actualizan trimestralmente. Esto se conoce como datos de los últimos doce meses (TTM) o de los últimos doce meses (LTM). Más información.

Modelo de análisis y copo de nieve

Los detalles del modelo de análisis utilizado para generar este informe están disponibles en nuestra página de Github, también tenemos guías sobre cómo utilizar nuestros informes y tutoriales en Youtube.

Conozca al que diseñó y construyó el modelo de análisis Simply Wall St.

Métricas industriales y sectoriales

Simply Wall St calcula cada 6 horas nuestras métricas sectoriales y de sección. Los detalles de nuestro proceso están disponibles en Github.

Fuentes analistas

Wacker Chemie AG está cubierta por 31 analistas. 11 de esos analistas presentaron las estimaciones de ingresos o ganancias utilizadas como datos para nuestro informe. Las estimaciones de los analistas se actualizan a lo largo del día.

AnalistaInstitución
Volker BosseBaader Helvea Equity Research
Konstantin WiechertBaader Helvea Equity Research
Laura Lopez PinedaBaader Helvea Equity Research